The focus on the rational use of antibiotics in dairy herds has meant that mastitis control has received renewed interest, particularly around prevention of new infections and alternative treatment strategies. The former has seen the development of a new industry initiative (QuarterPRO) to help advisors and farmers reduce the rate of new infections and index cases. The latter has seen widespread uptake of the selective use of intramammary antibiotic for infected cows at drying-off, a reminder to the veterinary profession as well as clients about the general lack of evidence for the use of parenteral antibiotic in combination with intramammary antibiotic for mild and moderate clinical mastitis events, and finally the potential to select intramammary antibiotic treatment for clinical mastitis using on farm culture (OFC). It is important that veterinary surgeons are aware of the research around the development and use of OFC and the suitability of individual herds for this approach. Whereas antibiotics may not be required for mild clinical mastitis events caused by some pathogens, particularly Escherichia coli, it is important that clinical mastitis events (particularly first cases in a lactation cycle) caused by Gram-positive pathogens such as Streptococcus spp. and Staphylococcus aureus are treated with intramammary antibiotic to optimise chance of cure and reduce risk of transmission. With this in mind, we need to consider individual herd cell count data, herd pathogen profile and ensure careful monitoring of outcomes for clinical mastitis cases in herds that are selecting treatment based on OFC, particularly for index (first) cases in a cow's lactation.
Read full abstract